Materion Corporation Reports Record Third Quarter 2023 Results
MAYFIELD HEIGHTS, Ohio–(BUSINESS WIRE)–Materion Corporation (NYSE: MTRN) today reported third quarter financial results and affirmed the midpoint of... Read more.
Ferguson plc: Block Listing Six Monthly Return
WOKINGHAM, England–(BUSINESS WIRE)– Name of applicant: Ferguson plc Name of scheme: Ferguson Group International Sharesave Plan 2011 Period of return:... Read more.
ATS to Participate in the Baird 2023 Global Industrial Conference
CAMBRIDGE, Ontario–(BUSINESS WIRE)–ATS Corporation (TSX and NYSE: ATS) (“ATS” or the “Company”), an industry-leading automation solutions provider,... Read more.
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Gemcitabine and Cisplatin as Treatment for Patients With Locally Advanced Unresectable or Metastatic Biliary Tract Cancer
Approval based on results from the Phase 3 KEYNOTE-966 trial, which demonstrated significant overall survival benefit in these patients versus chemotherapy alone... Read more.
The Estée Lauder Companies Reports Fiscal 2024 First Quarter Results
Net Sales Decreased 10% and Diluted EPS Declined to $.09 Organic Net Sales1 Declined 11% and Adjusted Diluted EPS Decreased to $.11 Delivered First Quarter Expectations... Read more.
Kolibri Global Energy Inc. Announces Bank Line Redetermination
THOUSAND OAKS, Calif.–(BUSINESS WIRE)–Kolibri Global Energy Inc. (the “Company” or “KEI”) (TSX: KEI, NASDAQ: KGEI) is pleased to announce the... Read more.
IDEXX Laboratories Announces Third Quarter Results
Achieves third quarter revenue growth of 9% reported and 8% organic, driven by CAG Diagnostics recurring revenue growth of 10% reported and 9% organic Solid revenue... Read more.
Humana Reports Third Quarter 2023 Financial Results; Affirms Full Year 2023 Adjusted EPS Guidance
Reports 3Q23 earnings per share (EPS) of $6.71 on a GAAP basis, Adjusted EPS of $7.78; reports YTD 2023 EPS of $24.26 on a GAAP basis, $26.10 on an Adjusted basis... Read more.
Karuna Therapeutics to Present at Upcoming Investor Conferences
BOSTON–(BUSINESS WIRE)–Karuna Therapeutics, Inc. (NASDAQ: KRTX), a biopharmaceutical company driven to discover, develop, and deliver transformative... Read more.
Trane Technologies Reports Strong Results and Raises 2023 Revenue and EPS Guidance
Highlights (third-quarter 2023 versus third-quarter 2022, unless otherwise noted): Reported revenues of $4.9 billion, up 12 percent; organic revenues* up 9 percent... Read more.